Harvard Bioscience to Present at Inaugural Equities.com Small-Cap Stars Conference at the NASDAQ MarketSite in New York City on December 18, 2014

HOLLISTON, Mass., Dec. 16, 2014 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, will present at the inaugural equities.com Small-Cap Stars Conference at the NASDAQ MarketSite in New York City on December 18, 2014. Jeffrey Duchemin, President and Chief Executive Officer, and Robert Gagnon, Chief Financial Officer, will present at 2:50 pm ET.

Management will also be available for one-on-one meetings throughout the day. Meetings can be arranged through the conference website or by calling 212-825-3210.

The equities.com Small-Cap Stars Conference brings together emerging growth and under-covered small cap companies to meet with an audience consisting of members of the investment community.

About Harvard Bioscience

Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of solutions to advance life science. Our products are sold to thousands of researchers in over 100 countries through our global sales organization, catalogs, websites, and through distributors including GE Healthcare, Thermo Fisher Scientific Inc., VWR and other specialized distributors. We have sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden, Spain, France and Canada. For more information, please visit our website at www.harvardbioscience.com.

The Harvard Bioscience logo is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=23828

For investor inquiries, please call (508) 893-8066. Press releases may be found on our web site.

CONTACT: Harvard Bioscience Jeffrey A. Duchemin President and Chief Executive Officer Tel: (508) 893-8999 Investor and Public Relations: Dian Griesel Int'l. Cheryl Schneider/Susan Forman (212) 825-3210

Source:Harvard Bioscience, Inc.